Listed

Opus Genetics, Inc.: Form 10-Q for the period ended Mar 31, 2017

Filed with the SEC on May 3, 2017 and accepted by EDGAR at May 3, 2017, 16:28 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2017-01-01 to 2017-03-31$2.3mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2017-01-01 to 2017-03-31−$4.0mus-gaap:OperatingIncomeLoss
Net income3 months2017-01-01 to 2017-03-31−$21.6mus-gaap:NetIncomeLoss
Cash and equivalentsAt period end2017-03-31$10.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-03-31$19.5mus-gaap:AssetsCurrent
Total assetsAt period end2017-03-31$19.6mus-gaap:Assets
Total liabilitiesAt period end2017-03-31$18.5mus-gaap:Liabilities
Shareholders' equityAt period end2017-03-31$1.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001140361-17-018125. Last ingested by Listed: Nov 12, 2026, 19:22 ET. Listed shows no prices and gives no investment advice.